An international research group led by the Helmholtz Center for Infection Research (HZI) has discovered a promising new drug candidate against severe lung infections caused by the hospital germ Staphylococcus aureus. The study, which has just been published in Cell Host & Microbe, describes for the first time how small molecules from the quinoxalinedione class specifically block the bacterial toxin α-hemolysin—a key trigger of tissue damage and inflammation. An international research group led by the Helmholtz Center for Infection Research (HZI) has discovered a promising new drug candidate against severe lung infections caused by the hospital germ Staphylococcus aureus. The study, which has just been published in Cell Host & Microbe, describes for the first time how small molecules from the quinoxalinedione class specifically block the bacterial toxin α-hemolysin—a key trigger of tissue damage and inflammation. Cell & Microbiology Molecular & Computational biology Phys.org – latest science and technology news stories
New agent inhibits Staphylococcus aureus toxin—giving hope to pneumonia patients
